We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Next Generation Quantitative MRI Solution Offers Unprecedented Resolution and Accuracy in Brain Imaging

By MedImaging International staff writers
Posted on 29 Dec 2023
Print article
Image: SyMRI 3D has obtained approval in the EU and is now CE-Marked (Photo courtesy of SyntheticMR)
Image: SyMRI 3D has obtained approval in the EU and is now CE-Marked (Photo courtesy of SyntheticMR)

Magnetic Resonance Imaging (MRI) is the preferred method for visualizing soft tissues of the brain, but diagnosis is often based on subjective assessment. Now, a next-generation imaging solution with isotropic 3D resolution is poised to revolutionize the field of medical imaging by introducing a myriad of innovative applications within its post-processing solution.

SyntheticMR’s (Linköping, Sweden) new 3D release, SyMRI 3D, enables precise volumetric estimations of brain regions, a technique commonly referred to as parcellation, which empowers clinicians to gain deeper insights into brain structure and function. Furthermore, the exceptional resolution provided by SyMRI 3D facilitates comprehensive lesion analysis, ensuring a more accurate and in-depth assessment of medical conditions. The advanced SyMRI sequence introduces 3D resolution to quantitative values and tissue segmentations, ensuring the same level of precision in quantification as achieved with SyMRI's 2D imaging. SyMRI 3D has obtained approval in the EU and is now CE-Marked with preparations in place for its commercial launch at the start of 2024.

"We are delighted to see our 3D solution CE-marked and available on the European market," said Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

"This advanced sequence extends 3D resolution to quantitative values and tissue segmentations, matching the precision achieved in SyMRI's 2D imaging. The CE-marking for SyMRI 3D paves the way for physicians to make more informed decisions through quantitative imaging," added Kyle Frye, CCO & President of SyntheticMR Inc. "Receiving approval for SyMRI 3D will allow us to enable physicians to make better, more informed decisions using quantitative imaging."

Related Links:
SyntheticMR 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Remote Controlled Digital Radiography and Fluoroscopy System
Eco Track-DRF - MARS 50/MARS50+/MARS 65/MARS 80
Thyroid Shield
Standard Thyroid Shield
New
Color Doppler Ultrasound System
KC20

Print article

Channels

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.